RXRX logo

RXRX
Recursion Pharmaceuticals Inc

14,588
Mkt Cap
$2.07B
Volume
36,681.00
52W High
$12.36
52W Low
$3.54
PE Ratio
-2.20
RXRX Fundamentals
Price
$3.98
Prev Close
$3.56
Open
$3.74
50D MA
$4.46
Beta
2.65
Avg. Volume
20.64M
EPS (Annual)
-$1.69
P/B
1.87
Loading...
Loading...
News
all
press releases
Recursion Pharmaceuticals (NASDAQ:RXRX) Director Blake Borgeson Sells 220,000 Shares
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) Director Blake Borgeson sold 220,000 shares of the firm's stock in a transaction on Tuesday, February 3rd. The stock was sold at an...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $8.66 Million Stock Position in Recursion Pharmaceuticals, Inc. $RXRX
IQ EQ FUND MANAGEMENT IRELAND Ltd increased its holdings in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Free Report) by 94.8% during the third quarter, according to its most recent 13F filing with...
MarketBeat·3d ago
News Placeholder
Biotech Stocks To Add to Your Watchlist - February 5th
Danaher, argenex, Vertex Pharmaceuticals, Moderna, Recursion Pharmaceuticals, United Therapeutics, and Medpace are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...
MarketBeat·4d ago
News Placeholder
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Receives Average Recommendation of "Hold" from Brokerages
Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX - Get Free Report) have received an average recommendation of "Hold" from the six research firms that are covering the company, MarketBeat...
MarketBeat·4d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights
In the closing of the recent trading day, Recursion Pharmaceuticals (RXRX) stood at $3.9, denoting a -4.88% move from the preceding trading day.
Zacks·4d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Declines More Than Market: Some Information for Investors
Recursion Pharmaceuticals (RXRX) reached $4.32 at the closing of the latest trading day, reflecting a -3.36% change compared to its last close.
Zacks·10d ago
News Placeholder
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift PR Newswire VANCOUVER, BC, Jan. 29, 2026...
PR Newswire·11d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.73, representing a -4.64% change from its previous close.
Zacks·16d ago
News Placeholder
Recursion Pharmaceuticals (NASDAQ:RXRX) Shares Up 10.8% - Here's Why
Recursion Pharmaceuticals (NASDAQ:RXRX) Stock Price Up 10.8% - Should You Buy...
MarketBeat·18d ago
News Placeholder
Biotech Stocks To Keep An Eye On - January 22nd
Moderna, Brainstorm Cell Therapeutics, ImmunityBio, Danaher, Vertex Pharmaceuticals, argenex, and Recursion Pharmaceuticals are the seven Biotech stocks to watch today, according to MarketBeat's...
MarketBeat·18d ago
<
1
2
...
>

Latest RXRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.